The rapid nongenomic actions of 1α,25‐dihydroxyvitamin D3 modulate the hormone‐induced increments in osteocalcin gene transcription in osteoblast‐like cells

Authors:

Abstract
We have previously shown that one of the rapid nongenomic actions of 1α,25‐dihydroxyvitamin D3 (1α,25‐(OH)2D3), the increase in intracellular calcium (Ca2+), accompanies the increased osteocalcin (OC) mRNA steady‐state levels in rat osteosarcoma cells. To determine the functional significance of the nongenomic actions, we have measured changes in intracellular Ca2+ as an indicator of the rapid effects and have assessed the effect of inhibition of the rapid increase in cellular Ca2+ by the inactive epimer, 1β,25‐dihydroxyvitamin D3 (1β,25‐(OH)2D3) on OC mRNA steady‐state levels and transcription. 1β,25‐dihydroxyvitamin D3 inhibited 1α,25‐(OH)2D3 induced increases in intracellular Ca2+ and OC mRNA transcription at 1 hr and OC mRNA steady state levels at 3 hr. 1β,25‐Dihydroxyvitamin D3 did not alter the binding of the vitamin D receptor complex to the vitamin D responsive element of the OC gene. The results demonstrate the functional importance of the rapid, nongenomic actions of 1α,25‐(OH)2D3 in the genomic activation of the OC gene by the hormone in rat osteoblast‐like cells, perhaps by modifying subtle structural and/or functional properties of the vitamin D–receptor DNA complex or by affecting other protein DNA interactions that support OC gene transcription.

This publication has 24 references indexed in Scilit: